Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LSI Industries | LYTS | Mar 14, 2025 | 17.32 | +1.64 |
Ltc Properties | LTC | Mar 14, 2025 | 35.96 | +1.90 |
Lucas GC | LGCL | Mar 14, 2025 | 0.62 | +1.66 |
Lucid Diagnostics | LUCD | Mar 14, 2025 | 1.39 | +8.59 |
Lucid Group | LCID | Mar 14, 2025 | 2.09 | +2.96 |
Lucky Strike Entertainment A | LUCK | Mar 14, 2025 | 9.67 | 0.00 |
Luda Technology Group Limited | LUD | Mar 14, 2025 | 4.36 | 0.00 |
Lufax ADR | LU | Mar 14, 2025 | 3.19 | +3.57 |
Lululemon Athletica | LULU | Mar 14, 2025 | 311.03 | +0.44 |
Lulus Fashion Lounge | LVLU | Mar 14, 2025 | 0.43 | -6.44 |
Lumen Technologies | LUMN | Mar 14, 2025 | 4.87 | +4.73 |
Lument Finance Trust | LFT | Mar 14, 2025 | 2.75 | +1.48 |
Lument Finance Trust A Pref | LFT-A | Mar 14, 2025 | 22.59 | +0.62 |
Lumentum | LITE | Mar 14, 2025 | 63.61 | +5.51 |
Luminar Technologies A | LAZR | Mar 14, 2025 | 5.05 | +7.91 |
Luokung Technology | LKCO | Mar 14, 2025 | 1.35 | +3.54 |
Luxfer | LXFR | Mar 14, 2025 | 12.12 | +0.92 |
Lxp Industrial Trust | LXP | Mar 14, 2025 | 9.06 | +1.68 |
LXP Industrial Trust C Pref | LXP-C | Mar 14, 2025 | 47.62 | -0.23 |
Lyell Immunopharma | LYEL | Mar 14, 2025 | 0.59 | -3.45 |
Lyft A | LYFT | Mar 14, 2025 | 11.92 | +5.77 |
LyondellBasell Industries Nv A | LYB | Mar 14, 2025 | 74.15 | +2.12 |
Lyra Therapeutics | LYRA | Mar 14, 2025 | 0.17 | -1.71 |
Lytus Technologies | LYT | Mar 14, 2025 | 0.11 | -20.07 |
LZ Technology B | LZMH | Mar 14, 2025 | 9.23 | 0.00 |
M&T Bank | MTB | Mar 14, 2025 | 175.59 | +3.00 |
M&T Bank ADR Prej J | MTB-J | Mar 14, 2025 | 26.60 | +0.15 |
M&T Bank H Pref | MTB-H | Mar 14, 2025 | 24.51 | +0.20 |
M-tron Industries | MPTI | Mar 14, 2025 | 37.99 | +4.43 |
M/I Homes | MHO | Mar 14, 2025 | 117.22 | +2.08 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.